| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ewa Wunsch | Q57080936 |
| Piotr Milkiewicz | Q58841590 | ||
| P2093 | author name string | Karsten Conrad | |
| Marcin Krawczyk | |||
| Peter Schierack | |||
| Yudong Liu | |||
| Dirk Roggenbuck | |||
| Maria Papp | |||
| Steffi Lopens | |||
| P2860 | cites work | Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD) | Q22242039 |
| Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review | Q22250934 | ||
| High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease | Q22250942 | ||
| Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease | Q22251082 | ||
| Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci | Q24618592 | ||
| The risk of colorectal cancer in ulcerative colitis: a meta-analysis | Q24669747 | ||
| Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein | Q24672879 | ||
| Biliary Mucosal Barrier and Microbiome | Q26782887 | ||
| Using GWAS to identify genetic predisposition in hepatic autoimmunity | Q26782991 | ||
| Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges | Q26823779 | ||
| Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease. | Q45955692 | ||
| Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity | Q46066476 | ||
| Species-specific and pathotype-specific binding of bacteria to zymogen granule membrane glycoprotein 2 (GP2). | Q46859509 | ||
| Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. | Q47758448 | ||
| Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior | Q47813954 | ||
| Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis. | Q48267704 | ||
| Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases | Q48362020 | ||
| Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease | Q49985633 | ||
| A Case of Suspected Hepatically Localized Granulomatosis with Polyangiitis | Q50055795 | ||
| Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. | Q51646246 | ||
| Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. | Q52039443 | ||
| Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients. | Q52723572 | ||
| Autoreactivity to isoforms of glycoprotein 2 in inflammatory bowel disease. | Q52870242 | ||
| Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis. | Q52909993 | ||
| Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. | Q53257455 | ||
| Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. | Q53561522 | ||
| Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. | Q54372805 | ||
| Glycoprotein synthesis in the adult rat pancreas. IV. Subcellular distribution of membrane glycoproteins | Q54586822 | ||
| Sulphite oxidase (SO) - a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis. | Q55000642 | ||
| Primary sclerosing cholangitis | Q57116825 | ||
| Primary sclerosing cholangitis - a comprehensive review | Q57124509 | ||
| Identification of a novel autoantigen in inflammatory bowel disease by protein microarray | Q57265358 | ||
| Immune reactivity to -tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders | Q57265359 | ||
| Pancreatic Autoantibodies in Inflammatory Bowel Disease | Q57265453 | ||
| The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview | Q58119564 | ||
| Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch | Q58573712 | ||
| Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype | Q58697836 | ||
| Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis | Q58760272 | ||
| PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease | Q60301715 | ||
| Clinical importance of organ-specific antibodies in ulcerative colitis and Crohn disease | Q67898113 | ||
| Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease | Q68222660 | ||
| Recurrence of Crohn's disease in the neo-terminal ileum and colonic factors | Q68323606 | ||
| IgA plasma cells in biliary mucosa: a likely source of locally synthesized IgA in human hepatic bile | Q70458575 | ||
| Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases | Q70588163 | ||
| Granulocyte specific antinuclear antibodies in ulcerative colitis. Aid in differential diagnosis of inflammatory bowel disease | Q70989529 | ||
| Biosynthesis of the major glycoprotein associated with zymogen-granule membranes in the pancreas | Q71737175 | ||
| Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis | Q72595809 | ||
| Serum autoantibodies in patients with primary sclerosing cholangitis | Q73523422 | ||
| A submembranous matrix of proteoglycans on zymogen granule membranes is involved in granule formation in rat pancreatic acinar cells | Q73821953 | ||
| MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease) | Q73851577 | ||
| Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group | Q74194596 | ||
| Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease | Q74638989 | ||
| Absence of the major zymogen granule membrane protein, GP2, does not affect pancreatic morphology or secretion | Q80601058 | ||
| Association of antibodies to exocrine pancreas with subtypes of Crohn's disease | Q81264456 | ||
| DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis | Q84565433 | ||
| Ulcerative colitis | Q84851901 | ||
| p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ | Q84968332 | ||
| Loss of tolerance to one or two major targets in Crohn's disease or just cross-reactivity? | Q85931246 | ||
| Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease | Q86028278 | ||
| Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies | Q86095389 | ||
| Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease | Q88120101 | ||
| Pancreatic anti-GP2 and anti-Saccharomyces cerevisiae antibodies in ruminants with paratuberculosis: A better understanding of the immunopathogenesis of Crohn's disease | Q89609858 | ||
| The Roles of Peyer's Patches and Microfold Cells in the Gut Immune System: Relevance to Autoimmune Diseases | Q90931306 | ||
| Diagnostic and clinical significance of antigen-specific pancreatic antibodies in inflammatory bowel diseases: A meta-analysis | Q92980076 | ||
| CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases | Q26999045 | ||
| The Role of Laboratory Tests in Crohn's Disease | Q28075045 | ||
| Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
| Crohn's disease | Q28273481 | ||
| Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response | Q28506068 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| Isolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitis | Q30895822 | ||
| Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease | Q33473077 | ||
| The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae | Q33486161 | ||
| Pancreatic autoantibodies in Crohn's disease: a family study | Q33617977 | ||
| Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? | Q33710290 | ||
| Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. | Q33730054 | ||
| GP2, the homologue to the renal cast protein uromodulin, is a major component of intraductal plugs in chronic pancreatitis | Q34110248 | ||
| The zymogen granule protein 2 (GP2) binds to scavenger receptor expressed on endothelial cells I (SREC-I). | Q34156890 | ||
| Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA. | Q34199391 | ||
| Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. | Q34328076 | ||
| Anti-neutrophil antibodies in primary sclerosing cholangitis | Q34329852 | ||
| Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease. | Q34367414 | ||
| A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis | Q34369987 | ||
| The presence in experimental animals of a colon specific Mr 40,000 protein(s) with relevance to ulcerative colitis | Q34393902 | ||
| Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease | Q34395670 | ||
| Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2. | Q34472649 | ||
| PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC). | Q34514665 | ||
| Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis | Q34528389 | ||
| Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response | Q34565942 | ||
| Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae | Q34627174 | ||
| Glycoprotein 2 antibodies in Crohn's disease. | Q34750329 | ||
| Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease | Q34976051 | ||
| Chronic intestinal failure after Crohn disease: when to perform transplantation | Q35232824 | ||
| Visualization of the entire differentiation process of murine M cells: suppression of their maturation in cecal patches | Q35356927 | ||
| Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA. | Q35523768 | ||
| Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype | Q35571282 | ||
| High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6 | Q35594752 | ||
| Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease | Q35654500 | ||
| Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci | Q36101099 | ||
| Immunopathogenesis of primary sclerosing cholangitis | Q36119469 | ||
| Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases | Q36119478 | ||
| The broad distribution of GP2 in mucous glands and secretory products | Q36230851 | ||
| Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies | Q36360510 | ||
| Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease | Q36631460 | ||
| The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells | Q36991688 | ||
| The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy | Q37096344 | ||
| The geoepidemiology of autoimmune intestinal diseases | Q37630785 | ||
| Glycoprotein 2 (GP2): grabbing the FimH bacteria into M cells for mucosal immunity. | Q37862092 | ||
| Deciphering the genetic predisposition to primary sclerosing cholangitis | Q37871484 | ||
| Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. | Q37943676 | ||
| Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found | Q38008773 | ||
| Diagnosis and classification of Crohn's disease. | Q38178476 | ||
| Diagnosis and classification of ulcerative colitis | Q38178485 | ||
| Re-thinking the functions of IgA(+) plasma cells | Q38284611 | ||
| Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease | Q38468388 | ||
| Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype. | Q38813594 | ||
| Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis | Q38919832 | ||
| Updates on Precancerous Lesions of the Biliary Tract: Biliary Precancerous Lesion | Q38992742 | ||
| Molecular classification of Crohn's disease reveals two clinically relevant subtypes. | Q39289701 | ||
| Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses. | Q39297770 | ||
| Diagnostic value of the antiglycoprotein-2 antibody for Crohn's disease: a PRISMA-compliant systematic review and meta-analysis | Q39364535 | ||
| Crohn's disease of the duodenum complicated by pancreatitis and common bile duct obstruction | Q39500266 | ||
| Possible diagnostic test for Crohn's disease by use of buccal mucosa | Q39507744 | ||
| Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells. | Q39975699 | ||
| Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. | Q40041740 | ||
| Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease | Q40141872 | ||
| Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease | Q40418336 | ||
| Exocrine granule specific packaging signals are present in the polypeptide moiety of the pancreatic granule membrane protein GP2 and in amylase: implications for protein targeting to secretory granules | Q40792824 | ||
| Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]. | Q40945601 | ||
| Factors determining the aggregation of urinary mucoprotein | Q41214773 | ||
| Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia | Q41348351 | ||
| Crohn's disease-specific anti-CUZD1 pancreatic antibodies are absent in ruminants with paratuberculosis. | Q41552732 | ||
| "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines | Q41752982 | ||
| The major protein of pancreatic zymogen granule membranes (GP-2) is anchored via covalent bonds to phosphatidylinositol | Q41908083 | ||
| Role of the microbiota and antibiotics in primary sclerosing cholangitis | Q42174395 | ||
| Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis | Q42202909 | ||
| Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease | Q42720701 | ||
| Autoantibodies in human ulcerative colitis | Q42823760 | ||
| In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells | Q42827778 | ||
| Crohn's disease-specific pancreatic autoantibodies are specifically present in ruminants with paratuberculosis: implications for the pathogenesis of the human disease. | Q43495069 | ||
| Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch | Q43680877 | ||
| Reply to Dr. Pavlidis et al's letter | Q43705289 | ||
| A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes | Q43883077 | ||
| Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis | Q43948285 | ||
| Distribution of Peyer's patches in the distal ileum | Q43972957 | ||
| Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis | Q44811389 | ||
| PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease | Q44959039 | ||
| Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease | Q45233019 | ||
| The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis | Q45358715 | ||
| P433 | issue | 1 | |
| P921 | main subject | primary sclerosing cholangitis | Q1058608 |
| sclerosing cholangitis | Q18554727 | ||
| P304 | page(s) | 6 | |
| P577 | publication date | 2020-03-16 | |
| P1433 | published in | Autoimmunity highlights | Q26853848 |
| P1476 | title | The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia | |
| P478 | volume | 11 |
Search more.